Q: Do you have any thoughts on RVX at this point in its development? Its latest press release sounds promising
Cathy

Q: Last week, Resverlogix received a positive confirmation from the FDA that it would likely support approval of BETon MACE based on the result of its Phase 3 study. The stock moved up ~28% today. It shows great promise in treating types of cardiovascular disease. From your experience, is it normal for the FDA to offer a positive comment? Would you have an opinion based on the FDA comment to open a position? I am a prudent investor yet have room for higher risk opportunities.
Thank you

Q: This TSX listed stock has been quite volatile and up nicely this year. Any comments regarding future growth?
GUY R